Extensive in vitro data unequivocally demonstrate that in breast cancer cell lines, GDNF promotes cell migration and survival in an RET-dependent manner, rendering cells insensitive to anticancer drugs targeting EsR or aromatase. The gene discussed is RET; the disease is breast carcinoma.